Cancer and Nanotechnology
Nanotechnology can probably build the selectivity, organic methodologies and power of concoction for stimulating the death of the diseased cells while limiting damage to non-malignant cells. Materials on the nanoscale are progressively being focused to malignancy cells with extraordinary specificity through both active and passive targeting. Chemotherapeutics in general cause harm to the immune system and alternative organs due to their nonspecific targeting, absence of solvency, and failure to enter the tumour centre bringing about weakened treatment with decreased dosage and low survival rate. Nanotechnology aids in the rapid and sensitive detection of cancer-related targets, enabling scientists to detect changes at the molecular level even if they occur in a small percentage of cells. Additionally, Nanotechnology also has the potential to generate unique and extremely effective therapeutic agents.